See also
this year's filing and
all EDGAR filings for this company.
PDF Report 0001642380_2022_Oncocyte_Corp.pdf
Logs
info |
Added remainder_ComprehensiveNetIncome directly from 10K |
industry.us_generic |
{} |
Graph
Absolute values for 0001642380, Oncocyte Corp
|
xvar |
xval |
0 |
LiabilitiesNoncurrent |
0 |
1 |
LiabilitiesCurrent |
14,120,000 |
2 |
remainder_Liabilities |
80,226,000 |
3 |
AssetsCurrent |
39,143,000 |
4 |
AssetsNoncurrent |
264,000 |
5 |
PropertyPlantAndEquipmentNet |
0 |
6 |
Goodwill |
109,929,000 |
7 |
remainder_Assets |
10,227,000 |
8 |
GeneralAndAdministrativeExpense |
37,688,000 |
9 |
ResearchAndDevelopmentExpense |
13,631,000 |
10 |
remainder_Expenses |
21,359,000 |
11 |
remainder_Revenues |
7,727,000 |
12 |
remainder_NetIncome |
854,000 |
13 |
remainder_ComprehensiveNetIncome |
37,000 |
|
yvar |
yval |
0 |
Liabilities |
94,346,000 |
1 |
Assets |
159,563,000 |
2 |
Expenses |
72,678,000 |
3 |
Revenues |
7,727,000 |
4 |
StockholdersEquity |
65,217,000 |
5 |
NetIncome |
-64,097,000 |
6 |
ComprehensiveNetIncome |
-64,078,500 |
7 |
BaseVar |
167,602,500 |
8 |
EconomicCapitalRatio |
-0.0681 |
Edgar->Model Mapping
Feature Distribution
Change over Time